USE OF PCR FOR DIAGNOSING HIV-1 INFECTION IN CHILDREN

Information

  • Research Project
  • 3506123
  • ApplicationId
    3506123
  • Core Project Number
    R44AI029234
  • Full Project Number
    5R44AI029234-03
  • Serial Number
    29234
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/1990 - 34 years ago
  • Project End Date
    8/31/1994 - 30 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1993 - 31 years ago
  • Budget End Date
    8/31/1994 - 30 years ago
  • Fiscal Year
    1993
  • Support Year
    3
  • Suffix
  • Award Notice Date
    8/22/1993 - 31 years ago

USE OF PCR FOR DIAGNOSING HIV-1 INFECTION IN CHILDREN

Studies conducted in the course of this grant are aimed at establishing the significance of PCR based assays for the diagnosis of pediatric HIV-1 infection and prediction of eventual progression to disease. A simple, rapid, reliable assay suitable for routine clinical testing will be developed and evaluated for the direct detection of HIV-1 sequences in seropositive babies. This assay will consist of polymerase chain reaction (PCR) amplification of two regions of the HIV-1 genome coupled with an oligomer capture assay in a microtiter well format. The specificity and sensitivity of this assay will be evaluated on laboratory control specimens, and an optimum format selected. The procedures for complete PCR testing of clinical samples including sample preparation, amplification, and detection will be streamlined to reduce handling and incubation times. Appropriate controls will be provided to validate the results of the assay. Additional modifications to the assay will be designed to permit detection of HIV-1 RNA sequences and to quantitate the PCR results. The RNA test may serve as a useful indicator of active infection and may be predictive of progression of disease. The quantitative assay will permit measurement of viral load and be useful for monitoring the response to anti-retroviral treatment. The tests developed in the course of this grant will permit more meaningful diagnosis of HIV-1 infected babies and allow better management of infection.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R44
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    BIOTECH RESEARCH LABORATORIES
  • Organization Department
  • Organization DUNS
  • Organization City
    ROCKVILLE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20850
  • Organization District
    UNITED STATES